Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 29 March 2011
[DOI: 10.1126/scisignal.2001556]

Supplementary Materials for:

c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance

Slovénie Pyndiah, Satoshi Tanida, Kazi M. Ahmed, Erica K. Cassimere, Chungyoul Choe, Daitoku Sakamuro*

*To whom correspondence should be addressed. E-mail: dsakam{at}

This PDF file includes:

  • Fig. S1. Exogenous BIN1 has a capacity to sensitize the DU145 prostate cancer cell line to cisplatin similar to that of exogenous p53.
  • Fig. S2. Depletion of BIN1 renders the SK-MEL-28 melanoma cell line resistant to cisplatin.
  • Fig. S3. Depletion of BIN1 renders the LNCaP prostate cancer cell line resistant to doxorubicin.
  • Fig. S4. The SK-MEL-28/CDDP-R cell line acquires resistance to doxorubicin and camptothecin.
  • Fig. S5. Establishment of SKOV3 ovarian cancer cell lines stably expressing BIN1 or BIN1ΔMBD.
  • Fig. S6. In situ immunofluorescence microscopic analysis of BIN1 proteins.
  • Fig. S7. BIN1 increases cisplatin sensitivity in an MBD-dependent manner.
  • Fig. S8. Clonogenic assay for cisplatin-dependent cytotoxicity in the presence or absence of BIN1.
  • Fig. S9. BIN1 and 10058-F4 inhibit c-MYC–mediated transactivation.
  • Fig. S10. BIN1 BAR domain is essential for BIN1-PARP1 interaction.
  • Fig. S11. Recombinant GST, GST-BIN1, and GST-free BIN1 proteins.
  • Fig. S12. Depletion of PARP1 is sufficient to induce G2-M arrest.
  • Fig. S13. Western analysis of endogenous c-MYC abundance in the presence of cisplatin.
  • Fig. S14. The INR element at +1 in the BIN1 core promoter is important for c-MYC–mediated BIN1 gene repression.
  • Fig. S15. Depletion of MIZ1 decreases BIN1 promoter activity and BIN1 mRNA.
  • Fig. S16. 10058-F4 reduces the protein stability and nuclear localization of endogenous c-MYC.
  • Fig. S17. ChIP analysis of the BIN1 core promoter sequence with an anti-MIZ1 antibody in Rat1/c-MYC–ER cells.
  • Table S1. Chemicals, primary antibodies, and siRNAs (or shRNAs) used in this study.
  • Table S2. Oligonucleotides used in this study.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 1.02 MB


Citation: S. Pyndiah, S. Tanida, K. M. Ahmed, E. K. Cassimere, C. Choe, D. Sakamuro, c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance. Sci. Signal. 4, ra19 (2011).

© 2011 American Association for the Advancement of Science

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882